Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul-Aug;73(4):376-424.
doi: 10.3322/caac.21765. Epub 2022 Dec 13.

Cancer epigenetics in clinical practice

Veronica Davalos  1 , Manel Esteller  1   2   3   4
Affiliations
Free article
Review

Cancer epigenetics in clinical practice

Veronica Davalos et al. CA Cancer J Clin. 2023 Jul-Aug.
Free article

Abstract

Cancer development is driven by the accumulation of alterations affecting the structure and function of the genome. Whereas genetic changes disrupt the DNA sequence, epigenetic alterations contribute to the acquisition of hallmark tumor capabilities by regulating gene expression programs that promote tumorigenesis. Shifts in DNA methylation and histone mark patterns, the two main epigenetic modifications, orchestrate tumor progression and metastasis. These cancer-specific events have been exploited as useful tools for diagnosis, monitoring, and treatment choice to aid clinical decision making. Moreover, the reversibility of epigenetic modifications, in contrast to the irreversibility of genetic changes, has made the epigenetic machinery an attractive target for drug development. This review summarizes the most advanced applications of epigenetic biomarkers and epigenetic drugs in the clinical setting, highlighting commercially available DNA methylation-based assays and epigenetic drugs already approved by the US Food and Drug Administration.

Keywords: DNA methylation; cancer; epigenetic biomarkers; epigenetic drugs; epigenetics.

PubMed Disclaimer

References

REFERENCES

    1. Holliday R. The inheritance of epigenetic defects. Science. 1987;238(4824):163-170. doi:10.1126/science.3310230
    1. Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31-46. doi:10.1158/2159-8290.CD-21-1059
    1. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 1983;301(5895):89-92. doi:10.1038/301089a0
    1. Berdasco M, Esteller M. Clinical epigenetics: seizing opportunities for translation. Nat Rev Genet. 2019;20(2):109-127. doi:10.1038/s41576-018-0074-2
    1. Mattei AL, Bailly N, Meissner A. DNA methylation: a historical perspective. Trends Genet. 2022;38(7):676-707. doi:10.1016/j.tig.2022.03.010